Pfizer and Roche among sponsors of HTA data-sharing initiative

Pharma giants Pfizer (NYSE: PFE) and Roche (ROG: SIX) are two of seven sponsors announced for a pioneering project to generate, align and share disease-level data across an entire condition for health technology assessments (HTA).

The collaboration, known as HERCULES, will focus on medicines for Duchenne muscular dystrophy (DMD) with the aim of improving the chances of medicines for rare and orphan diseases to receive positive decisions from the UK’s National Institute for Health and Care Excellence, France’s Haute Autorité de Santé and other HTA bodies.

"HERCULES has the potential to transform HTA submissions in DMD and other rare diseases"